NCT01083966 2025-04-09Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular SchwannomaNorthwell HealthPhase 1 Suspended30 enrolled
NCT01125046 2021-01-22Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasNorthwestern UniversityPhase 2 Completed50 enrolled 13 charts
NCT01207687 2018-08-27Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)National Cancer Institute (NCI)Phase 2 Completed14 enrolled 28 charts